These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 11875709

  • 1. Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma.
    Werther K, Christensen IJ, Nielsen HJ, Danish RANX05 Colorectal Cancer Study Group.
    Br J Cancer; 2002 Feb 01; 86(3):417-23. PubMed ID: 11875709
    [Abstract] [Full Text] [Related]

  • 2. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
    Werther K, Christensen IJ, Brünner N, Nielsen HJ.
    Eur J Surg Oncol; 2000 Nov 01; 26(7):657-62. PubMed ID: 11078612
    [Abstract] [Full Text] [Related]

  • 3. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C, Coudert MC, Lepage E, Cabane J, Richard F.
    Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer.
    Nakayama Y, Sako T, Shibao K, Okazaki K, Rempo N, Onitsuka K, Minagawa N, Akahane K, Nagashima N, Nagata N, Itoh H.
    Anticancer Res; 2002 Dec 01; 22(4):2437-42. PubMed ID: 12174940
    [Abstract] [Full Text] [Related]

  • 5. Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer.
    Chin KF, Greenman J, Gardiner E, Kumar H, Topping K, Monson J.
    Br J Cancer; 2000 Dec 01; 83(11):1425-31. PubMed ID: 11076648
    [Abstract] [Full Text] [Related]

  • 6. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
    George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI.
    Clin Cancer Res; 2000 Aug 01; 6(8):3147-52. PubMed ID: 10955796
    [Abstract] [Full Text] [Related]

  • 7. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A, Höyhtyä M, Tavelin B, Stenling R, Lindmark G.
    Anticancer Res; 2000 Aug 01; 20(2B):1085-91. PubMed ID: 10810401
    [Abstract] [Full Text] [Related]

  • 8. Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer.
    Nakayama Y, Sako T, Shibao K, Onitsuka K, Nagashima N, Hirata K, Nagata N, Itoh H.
    Anticancer Res; 2000 Aug 01; 20(6A):4097-102. PubMed ID: 11131678
    [Abstract] [Full Text] [Related]

  • 9. The association between preoperative concentration of soluble vascular endothelial growth factor, perioperative blood transfusion, and survival in patients with primary colorectal cancer.
    Werther K, Christensen IJ, Nielsen HJ, Danish RANX05 Colorectal Cancer Study Group.
    Eur J Surg; 2001 Apr 01; 167(4):287-92. PubMed ID: 11354321
    [Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, Unger C, Marmé D, Gastl G.
    Cancer; 1999 Jan 01; 85(1):178-87. PubMed ID: 9921991
    [Abstract] [Full Text] [Related]

  • 11. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
    Tsai WS, Changchien CR, Yeh CY, Chen JS, Tang R, Chiang JM, Hsieh PS, Fan CW, Wang JY.
    Dis Colon Rectum; 2006 Jun 01; 49(6):883-94. PubMed ID: 16741643
    [Abstract] [Full Text] [Related]

  • 12. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.
    Salven P, Orpana A, Joensuu H.
    Clin Cancer Res; 1999 Mar 01; 5(3):487-91. PubMed ID: 10100697
    [Abstract] [Full Text] [Related]

  • 13. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer.
    Kumar H, Heer K, Lee PW, Duthie GS, MacDonald AW, Greenman J, Kerin MJ, Monson JR.
    Clin Cancer Res; 1998 May 01; 4(5):1279-85. PubMed ID: 9607588
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients: correlation with clinicopathological factors and tumor markers.
    Takeda A, Shimada H, Imaseki H, Okazumi S, Natsume T, Suzuki T, Ochiai T.
    Oncol Rep; 2000 May 01; 7(2):333-8. PubMed ID: 10671682
    [Abstract] [Full Text] [Related]

  • 15. [Determination of vascular endothelial growth factor (VEGF) concentration in serum of patients with colorectal carcinoma].
    Broll R, Erdmann H, Windhövel U, Duchrow M, Strik MW.
    Langenbecks Arch Chir Suppl Kongressbd; 1998 May 01; 115(Suppl I):315-8. PubMed ID: 14518267
    [Abstract] [Full Text] [Related]

  • 16. Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma.
    Akbulut H, Altuntas F, Akbulut KG, Ozturk G, Cindoruk M, Unal E, Icli F.
    Cytokine; 2002 Nov 24; 20(4):184-90. PubMed ID: 12543084
    [Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor (VEGF)--a valuable serum tumour marker in patients with colorectal cancer?
    Broll R, Erdmann H, Duchrow M, Oevermann E, Schwandner O, Markert U, Bruch HP, Windhövel U.
    Eur J Surg Oncol; 2001 Feb 24; 27(1):37-42. PubMed ID: 11237490
    [Abstract] [Full Text] [Related]

  • 18. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
    Cooper BC, Ritchie JM, Broghammer CL, Coffin J, Sorosky JI, Buller RE, Hendrix MJ, Sood AK.
    Clin Cancer Res; 2002 Oct 24; 8(10):3193-7. PubMed ID: 12374688
    [Abstract] [Full Text] [Related]

  • 19. Serum vascular endothelial growth factor is often elevated in disseminated cancer.
    Salven P, Mänpää H, Orpana A, Alitalo K, Joensuu H.
    Clin Cancer Res; 1997 May 24; 3(5):647-51. PubMed ID: 9815732
    [Abstract] [Full Text] [Related]

  • 20. Serum concentrations of vascular endothelial growth factor in vulvar cancer.
    Hefler L, Tempfer C, Obermair A, Frischmuth K, Sliutz G, Reinthaller A, Leodolter S, Kainz C.
    Clin Cancer Res; 1999 Oct 24; 5(10):2806-9. PubMed ID: 10537345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.